Goodrx Holdings Inc (GDRX)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $1.20B
Last updated: Nov 17, 2026 at 4:15 PM ET
Goodrx Holdings Inc (GDRX) Stock Chart
Goodrx Holdings (GDRX) has a latest price of $3.47 on Nov 17, 2026, 10.8% below its 52-week high of $3.89. Its price rose 16.8% over the past 12 months. The month-end price fell 92.2% over the 5 years through Oct 2026, a compound annual decline of 39.9%.
Price Chart
From Sep 2020 to Oct 2026, its highest month-end close was $55.60 in Sep 2020 and its lowest $1.87 in Feb 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GDRX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GDRX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 2.0%, and over 6 months it rose 37.7%. The month-end price fell 29.2% over the 3 years through Oct 2026, a compound annual decline of 10.9%.
| Period | Change |
|---|---|
| 1 month | +3.0% |
| 3 months | -2.0% |
| 6 months | +37.7% |
| 12 months | +16.8% |
| 12 months, with dividends | +16.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -29.2% | -10.9% |
| 5 years | -92.2% | -39.9% |
Price by Year
Its best calendar year was 2023, when the price rose 43.8%, and its weakest was 2022, when it fell 85.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.49 | +28.8% |
| 2025 | $2.71 | -41.7% |
| 2024 | $4.65 | -30.6% |
| 2023 | $6.70 | +43.8% |
| 2022 | $4.66 | -85.7% |
| 2021 | $32.68 | -19.0% |
Trading Range
The price is 0.8% above its 50-day average of $3.44 and 20.3% above its 200-day average of $2.88.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.47 | |
| 52-week high | $3.89 | -10.8% |
| 52-week low | $1.77 | +96.0% |
| 50-day average | $3.44 | +0.8% |
| 200-day average | $2.88 | +20.3% |
Price Risk
Over 3 years, its largest fall from a peak was 79.3%.
| Measure | Value |
|---|---|
| 1-year beta | 1.38 |
| Largest fall, 1 year | -35.5% |
| Largest fall, 3 years | -79.3% |
Valuation
Goodrx Holdings traded at 7.7x earnings at the end of 2025, against a 5-year median of 17.5x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GDRX
What is GDRX's 1-year price change?
Goodrx Holdings's price rose 16.8% over the past 12 months. With dividends included, the 12-month total return was 16.8%.
What is GDRX's 5-year price change?
Goodrx Holdings's month-end price fell 92.2% over the 5 years through Oct 2026, a compound annual decline of 39.9%. These figures leave out dividends.
What is GDRX's 52-week high and low?
Goodrx Holdings's 52-week high is $3.89 and its 52-week low is $1.77. Its latest price of $3.47 on Nov 17, 2026 is 10.8% below the high.
What is GDRX's beta?
Goodrx Holdings's 1-year beta against the S&P 500 is 1.38, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 35.5%.
Is the GDRX chart free?
Yes. Advanced Charting for GDRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GDRX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors